Home » Topics » BioWorld Science

BioWorld Science
RSS

Ketamine activates opioid system

Sep. 7, 2018

PI3Kdelta in autoimmunity

Sep. 7, 2018

Poseida notes data from ongoing phase I study of P-BCMA-101 in relapsed/refractory multiple myeloma

Sep. 6, 2018

Phase II TORTUGA trial of filgotinib in ankylosing spondylitis meets primary efficacy endpoint

Sep. 6, 2018

Phase III study of PET imaging agent flortaucipir F 18 meets primary endpoints

Sep. 6, 2018

Phoenix PharmaLabs receives support to study PPL-103 for cocaine addiction

Sep. 6, 2018

DSMB recommends continuation of phase IIb study of OPT-302 in wet AMD

Sep. 6, 2018

AIC-649 stimulates the immune system of patients with chronic HBV in phase I trial

Sep. 6, 2018

Adocia reports phase I data on BioChaperone Pramlintide Insulin in type 1 diabetes

Sep. 6, 2018

OncoArendi Therapeutics presents new AMCase and CHIT1 dual inhibitors for lung diseases

Sep. 6, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...